KALA PHARMACEUTICALS

kala-pharmaceuticals-logo

Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient-friendly format. The company's research efforts have demonstrated... successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept while establishing R&D collaborations with select partners to improve products in their pipelines.

#SimilarOrganizations #People #Financial #Website #More

KALA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2009-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.kalarx.com

Total Employee:
101+

Status:
Active

Contact:
1(781) 996-5252

Email Addresses:
[email protected]

Total Funding:
506.37 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Amazon IPv6


Similar Organizations

adastra-pharmaceuticals-logo

Adastra Pharmaceuticals

Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

amylyx-pharmaceuticals-logo

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimerโ€™s and other diseases of the brain.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

dyne-therapeutics-logo

Dyne Therapeutics

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

kiora-pharmaceuticals-logo

Kiora Pharmaceuticals

Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

phasebio-pharmaceuticals-logo

PhaseBio Pharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

venatorx-pharmaceuticals-logo

Venatorx Pharmaceuticals

Venatorx Pharmaceuticals develops a novel anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.

zietchick-research-institute-llc-logo

Zietchick Research Institute, LLC

The Zietchick Research Institute, LLC specializes in developing new treatments for eye diseases that primarily affect mothers and infants.


Current Advisors List

howard-rosen_image

Howard Rosen Board Member @ Kala Pharmaceuticals
Board_member
2014-01-01

ronald-lee-krall_image

Ronald Lee Krall Scientific Advisors @ Kala Pharmaceuticals
Advisor

bernard-gilly_image

Bernard Gilly Member of the Board of Directors @ Kala Pharmaceuticals
Board_member

peter-hutt_image

Peter Hutt Scientific Advisor @ Kala Pharmaceuticals
Advisor

rob-paull_image

Rob Paull Chairman - Nominating & Governance Committee @ Kala Pharmaceuticals
Board_member
2017-07-01

howie-rosen_image

Howie Rosen Scientific Advisors @ Kala Pharmaceuticals
Advisor

gregory-grunberg_image

Gregory Grunberg Board Member, Compensation Committee @ Kala Pharmaceuticals
Board_member
2015-04-01

kevin-bitterman_image

Kevin Bitterman Board Of Directors @ Kala Pharmaceuticals
Board_member

Current Employees Featured

spencer-alford_image

Spencer Alford
Spencer Alford VP, Biologics R&D @ Kala Pharmaceuticals
VP, Biologics R&D
2021-11-01

todd-bazemore_image

Todd Bazemore
Todd Bazemore Chief Operating Officer @ Kala Pharmaceuticals
Chief Operating Officer
2017-11-01

hongming-chen_image

Hongming Chen
Hongming Chen Chief Scientific Officer @ Kala Pharmaceuticals
Chief Scientific Officer
2010-01-01

robert-langer_image

Robert Langer
Robert Langer Co-Founder @ Kala Pharmaceuticals
Co-Founder
2009-01-01

greg-perry_image

Greg Perry
Greg Perry Audit Committee Chairman @ Kala Pharmaceuticals
Audit Committee Chairman
2018-03-01

mary-reumuth_image

Mary Reumuth
Mary Reumuth Chief Financial Officer @ Kala Pharmaceuticals
Chief Financial Officer
2017-07-01

kim-brazzell_image

Kim Brazzell
Kim Brazzell Chief Medical Officer @ Kala Pharmaceuticals
Chief Medical Officer
2013-01-01

andrea-franz_image

Andrea Franz
Andrea Franz Chief Financial Officer @ Kala Pharmaceuticals
Chief Financial Officer
2013-01-01

gregory-d-perry_image

Gregory D. Perry
Gregory D. Perry Audit Committee Chairman @ Kala Pharmaceuticals
Audit Committee Chairman
2018-03-01

justin-hanes_image

Justin Hanes
Justin Hanes Founder & Former Director @ Kala Pharmaceuticals
Founder & Former Director
2009-12-01

Founder


justin-hanes_image

Justin Hanes

robert-langer_image

Robert Langer

Stock Details


Company's stock symbol is NASDAQ:KALA

Investors List

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Kala Pharmaceuticals

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Equity - Kala Pharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series C - Kala Pharmaceuticals

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series C - Kala Pharmaceuticals

camcapital_image

CAM Capital

CAM Capital investment in Series C - Kala Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Kala Pharmaceuticals

longitude-capital_image

Longitude Capital

Longitude Capital investment in Series C - Kala Pharmaceuticals

lux-capital_image

Lux Capital

Lux Capital investment in Series C - Kala Pharmaceuticals

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Kala Pharmaceuticals

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Kala Pharmaceuticals

Official Site Inspections

http://www.kalarx.com Semrush global rank: 36.76 K Semrush visits lastest month: 3.58 M

  • Host name: aa0d276b28f6a5dd6.awsglobalaccelerator.com
  • IP address: 75.2.68.162
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Kala Pharmaceuticals" on Search Engine